1
Clinical Trials associated with SARS-CoV-2 Vaccine, Inactivated (Vero Cell)(Chinese Academy of Medical Sciences) / Unknown statusPhase 3IIT Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)
To evaluate the immunogenicity and safety of the third dose SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in adults aged 18 years and above, who inoculated the third dose after 6 months since finished two doses schedule of CoronaVac or BBIBP-CorV.
100 Clinical Results associated with SARS-CoV-2 Vaccine, Inactivated (Vero Cell)(Chinese Academy of Medical Sciences)
100 Translational Medicine associated with SARS-CoV-2 Vaccine, Inactivated (Vero Cell)(Chinese Academy of Medical Sciences)
100 Patents (Medical) associated with SARS-CoV-2 Vaccine, Inactivated (Vero Cell)(Chinese Academy of Medical Sciences)
100 Deals associated with SARS-CoV-2 Vaccine, Inactivated (Vero Cell)(Chinese Academy of Medical Sciences)